bitcoin
bitcoin

$104938.716253 USD

2.80%

ethereum
ethereum

$3965.152639 USD

1.90%

tether
tether

$0.999670 USD

0.00%

xrp
xrp

$2.409095 USD

-0.99%

solana
solana

$222.142097 USD

0.88%

bnb
bnb

$714.385402 USD

0.03%

dogecoin
dogecoin

$0.405621 USD

1.65%

usd-coin
usd-coin

$0.999917 USD

0.00%

cardano
cardano

$1.083264 USD

0.97%

tron
tron

$0.284069 USD

0.97%

avalanche
avalanche

$50.447525 USD

1.66%

chainlink
chainlink

$29.022383 USD

-1.65%

toncoin
toncoin

$6.379555 USD

2.25%

shiba-inu
shiba-inu

$0.000028 USD

0.16%

sui
sui

$4.822914 USD

8.47%

加密货币新闻

Control Bionics (ASX: CBL) 进军美国运动表现和日本神经康复市场

2024/12/16 08:51

Control Bionics (ASX: CBL) 已将其先进的 NeuroStrip 无线可穿戴设备的第一份商业协议扩展到美国运动表现和日本神经康复市场。

Control Bionics (ASX: CBL) 进军美国运动表现和日本神经康复市场

Control Bionics (ASX:CBL) has announced the first commercial agreements for its advanced NeuroStrip wireless wearable device, expanding into the US sports performance and Japanese neurological rehabilitation markets.

Control Bionics (ASX:CBL) 宣布了其先进 NeuroStrip 无线可穿戴设备的第一份商业协议,该设备将扩展到美国运动表现和日本神经康复市场。

These strategic partnerships will leverage Control Bionics' technology to drive better sports performance and patient outcomes, while also serving as platforms for expanding into other regions.

这些战略合作伙伴关系将利用 Control Bionics 的技术来提高运动表现和患者治疗效果,同时也作为扩展到其他地区的平台。

The company expects the agreements to diversify its market focus and generate material revenue through hardware sales of NeuroStrip and recurring software-as-a-service (SaaS) subscription fees.

该公司预计这些协议将使其市场重点多元化,并通过 NeuroStrip 的硬件销售和经常性软件即服务 (SaaS) 订阅费产生实质性收入。

Neuro Elite Athletics dealThe first commercial deal is with US-based Neuro Elite Athletics (NEA), where Control Bionics will acquire a 20% stake for a US$250,000 consideration, including cash and in-kind contributions.

Neuro Elite Athletics 交易第一个商业交易是与美国 Neuro Elite Athletics (NEA) 达成的,Control Bionics 将以 250,000 美元的价格收购其 20% 的股份,其中包括现金和实物捐助。

This investment is expected to rapidly accelerate the rollout of NEA's proprietary NeuroBounce jump improvement program, which is initially targeting domestic markets.

这项投资预计将迅速加速 NEA 专有的 NeuroBounce 跳跃改进计划的推出,该计划最初针对国内市场。

The program is described as the world's only computerised electromyography (EMG) training solution proven to increase an athlete's vertical leap by as much as 15 centimetres and enhance explosiveness in just a few sessions.

该计划被描述为世界上唯一的计算机化肌电图 (EMG) 训练解决方案,经证明只需几次训练即可将运动员的垂直弹跳提高多达 15 厘米并增强爆发力。

College focusNeuroBounce is being targeted to the more than 28,500 sports teams and 600,000 athletes on the lucrative US college circuit.

大学焦点NeuroBounce 的目标客户是利润丰厚的美国大学巡回赛中的 28,500 多个运动队和 600,000 名运动员。

NEA also plans to market the program to more than 300,000 high school teams nationwide with 7.9 million participants, presenting long-term growth potential for Control Bionics.

NEA 还计划向全国超过 300,000 个高中团队推广该项目,共有 790 万名参与者,为 Control Bionics 带来长期增长潜力。

Under the terms of the NEA acquisition, Control Bionics will receive direct revenue from hardware sales, software subscriptions and its share of NeuroBounce distributions.

根据 NEA 收购条款,Control Bionics 将从硬件销售、软件订阅以及 NeuroBounce 发行版中获得直接收入。

It will also have exclusive rights to market NeuroBounce in Australia and Japan.

它还将拥有 NeuroBounce 在澳大利亚和日本的独家营销权。

Stroke Lab agreementControl Bionics has also signed an agreement with Tokyo-based rehabilitation facility Stroke Lab to localise NeuroStrip technology for the Japanese market.

中风实验室协议Control Bionics 还与东京康复机构中风实验室签署了一项协议,将 NeuroStrip 技术本地化到日本市场。

The facility combines neurology and therapy to deliver evidence-based, personalised care and has proven expertise in surface EMG technology for stroke recovery.

该机构将神经病学和治疗结合起来,提供循证的个性化护理,并在中风康复的表面肌电图技术方面拥有经过验证的专业知识。

The deal establishes a framework for a joint operating agreement in the new year that will strengthen Control's foothold in Japan's advanced rehabilitation market.

该交易为新的一年的联合运营协议建立了框架,这将加强 Control 在日本先进康复市场的立足点。

Pivotal stepControl Bionics chief executive officer Jeremy Steele said the new commercial agreements mark a pivotal step in the company’s mission to harness neurotechnology for human empowerment.

Pivotal stepControl Bionics 首席执行官杰里米·斯蒂尔 (Jeremy Steele) 表示,新的商业协议标志着该公司利用神经技术增强人类使命的关键一步。

“These collaborations underscore our ability to enter and lead high-growth markets and drive innovation while delivering value for our shareholders,” he said.

他表示:“这些合作凸显了我们进入并引领高增长市场、推动创新、同时为股东创造价值的能力。”

“By strengthening our relationships with existing customers we have the opportunity to more rapidly scale our company, diversifying into new markets and generating recurring revenue to build a business that has a very promising future.”

“通过加强与现有客户的关系,我们有机会更快地扩大公司规模、多元化进入新市场并产生经常性收入,从而建立一个前景光明的业务。”

新闻来源:smallcaps.com.au

免责声明:info@kdj.com

The information provided is not trading advice. kdj.com does not assume any responsibility for any investments made based on the information provided in this article. Cryptocurrencies are highly volatile and it is highly recommended that you invest with caution after thorough research!

If you believe that the content used on this website infringes your copyright, please contact us immediately (info@kdj.com) and we will delete it promptly.

2024年12月16日 发表的其他文章